Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
Rutgers, The State University of New Jersey · Albert Einstein College of Medicine · +2 more institutions
Abstract
Twelve regulated cell death programs have been described. We review in detail the basic biology of nine including death receptor-mediated apoptosis, death receptor-mediated necrosis (necroptosis), mitochondrial-mediated apoptosis, mitochondrial-mediated necrosis, autophagy-dependent cell death, ferroptosis, pyroptosis, parthanatos, and immunogenic cell death. This is followed by a dissection of the roles of these cell death programs in the major cardiac syndromes: myocardial infarction and heart failure. The most important conclusion relevant to heart disease is that regulated forms of cardiomyocyte death play important roles in both myocardial infarction with reperfusion (ischemia/reperfusion) and heart…
Citation impact
- FWCI
- 78.86
- Percentile
- 100%
- References
- 573
Authors
5- DPDominic P. Del ReCorresponding
Rutgers, The State University of New Jersey, Albert Einstein College of Medicine, University of Washington, Rutgers New Jersey Medical School
- DADulguun Amgalan
Rutgers, The State University of New Jersey, Albert Einstein College of Medicine, University of Washington, Rutgers New Jersey Medical School
- ALAndreas Linkermann
Rutgers, The State University of New Jersey, Albert Einstein College of Medicine, University of Washington, Rutgers New Jersey Medical School
- QLQinghang Liu
Rutgers, The State University of New Jersey, Albert Einstein College of Medicine, University of Washington, Rutgers New Jersey Medical School
- RNRichard N. Kitsis
Rutgers, The State University of New Jersey, Albert Einstein College of Medicine, University of Washington, Rutgers New Jersey Medical School
Topics & keywords
- Pyroptosis
- Necroptosis
- Programmed cell death
- Necrosis
- Biology
- Ischemia
- Autophagy
- Apoptosis
- Good health and well-being
Funding
- UDU.S. Department of DefenseAward: PR151134P1
- AHAmerican Heart AssociationAwards: 18SRG34280018, 15PRE25080032, 15CSA26240000
- PPfizer
- NNovartis
- DFDeutsche Forschungsgemeinschaft
- FLFondation Leducq
- EKElse Kröner-Fresenius-Stiftung
- NINational Institutes of HealthAwards: R01HL127339, R15HL135726, R01HL128071, R01HL116507, R01HL130861, R01HL138475